Show simple item record

dc.contributor.authorDedieu, S
dc.contributor.authorCanron, X
dc.contributor.authorRezvani, H R
dc.contributor.authorBouchecareilh, M
dc.contributor.authorMazurier, F
dc.contributor.authorSinisi, R
dc.contributor.authorZanda, M
dc.contributor.authorMoenner, M
dc.contributor.authorBikfalvi, A
dc.contributor.authorNorth, S
dc.date.accessioned2014-11-21T10:57:01Z
dc.date.available2014-11-21T10:57:01Z
dc.date.issued2010-03-24
dc.identifier.citationDedieu , S , Canron , X , Rezvani , H R , Bouchecareilh , M , Mazurier , F , Sinisi , R , Zanda , M , Moenner , M , Bikfalvi , A & North , S 2010 , ' The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A ' BMC medicine , vol. 8 , 19 . https://doi.org/10.1186/1741-7015-8-19en
dc.identifier.issn1741-7015
dc.identifier.otherPURE: 995483
dc.identifier.otherPURE UUID: 95c9778b-62b5-42ad-9580-d05e225e33dc
dc.identifier.otherPubMed: 20334641
dc.identifier.otherScopus: 77952283596
dc.identifier.urihttp://hdl.handle.net/2164/3963
dc.format.extent14en
dc.language.isoeng
dc.relation.ispartofBMC medicineen
dc.rightsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleThe cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-Aen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/1741-7015-8-19


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record